kongre.net
Welcome to kongre.net

Speaker

Ann Boija

Chief Scientific Officer, Dewpoint Therapeutics

Ann Boija, Chief Scientific Officer at Dewpoint Therapeutics, spoke at 9th RNA-Targeted Drug Discovery & Development Summit (Boston, United States of America, 10–12 Nov 2026) in the session “Advancing First-in-Class Condensate Modulators for Previously Inaccessible Targets”.

Conferences
1
Keynotes
0
Upcoming
0

Past appearances

More speakers at 9th RNA-Targeted Drug Discovery & Development Summit

  • Scott Barraza

    Associate Director, Early Discovery Chemistry, PTC Therapeutics

  • Robert Batey

    Professor & Associate Chair of Graduate Affairs, University of Colorado Boulder

  • Andrea Casazza

    Head of Cancer Biology, EPICS Therapeutics

  • Tom Chappie

    Senior Principal Scientist & Research Fellow, Pfizer

  • Yann Foricher

    Head of Small Molecules Medicinal Chemistry, Sanofi

  • Dalya Gartzman

    Chief Executive Officer, Renasis Bio

See all 23 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Ann Boija, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].